Skip to main content
logo
Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.5621
-0.0369 (-6.16%)
Aug 10, 2026, 4:00 PM EDT - Market closed

Barinthus Biotherapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--14.970.844.70.27
Revenue Growth
--1766.46%-98.21%16580.22%-94.44%
Gross Profit
--14.970.844.70.27
Operating Income
-43.73-70.56-67.97-83.91-4.04-45.22
Net Income
-41.77-66.43-61.07-73.355.34-50.87
Earnings Per Share
-1.02-1.64-1.55-1.900.14-1.37
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
59.371.85110.66142.09194.39214.05
Total Debt
10.3-11.2812.0112.988.777.22
Net Cash (Debt)
4983.1398.66129.11185.61206.83
Net Cash Growth
-34.02%-15.73%-23.59%-30.44%-10.26%397.17%
Net Cash Per Share
1.202.052.513.344.935.56

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-26.43-46-27.15-50.93-14.43-32.58
Capital Expenditures
0-0.04-0.89-5.41-6.14-1.15
Free Cash Flow
-26.43-46.04-28.04-56.34-20.57-33.73
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---454.07%-10463.10%-9.04%-16873.50%
Pretax Margin
---409.03%-9541.40%1.90%-19082.09%
Profit Margin
---408.73%-9157.98%11.90%-19071.60%
FCF Margin
---187.34%-7024.69%-46.01%-12585.40%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----16.58-
PS Ratio
--3.25177.801.981541.67